| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
22,090 |
18,211 |
$5.57M |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
697 |
581 |
$146K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,335 |
11,724 |
$26K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,665 |
8,076 |
$20K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,779 |
2,185 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,908 |
1,422 |
$5K |
| 90686 |
|
2,439 |
2,005 |
$2K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
569 |
474 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,675 |
1,247 |
$929.58 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
169 |
97 |
$891.43 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
579 |
432 |
$799.96 |
| 90746 |
|
168 |
107 |
$624.90 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
191 |
138 |
$543.17 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,196 |
833 |
$452.02 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
539 |
321 |
$357.13 |
| 90677 |
|
37 |
27 |
$307.78 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
28 |
28 |
$288.48 |
| 82962 |
|
1,971 |
1,194 |
$228.11 |
| 90670 |
|
64 |
55 |
$169.65 |
| 90656 |
|
228 |
158 |
$161.96 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
160 |
126 |
$120.82 |
| 92552 |
|
927 |
815 |
$117.14 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
26 |
26 |
$96.56 |
| 82948 |
|
1,573 |
1,324 |
$79.77 |
| 85018 |
|
750 |
586 |
$78.29 |
| 81002 |
|
203 |
191 |
$67.46 |
| 90723 |
|
26 |
26 |
$66.15 |
| 90688 |
|
59 |
59 |
$65.32 |
| 90715 |
|
18 |
12 |
$37.96 |
| 90685 |
|
94 |
86 |
$9.45 |
| 90707 |
|
37 |
29 |
$9.45 |
| 81025 |
|
64 |
37 |
$8.82 |
| 81003 |
|
403 |
360 |
$1.85 |
| 1159F |
|
6,553 |
5,456 |
$0.00 |
| 3078F |
|
1,030 |
967 |
$0.00 |
| 1160F |
|
6,528 |
5,438 |
$0.00 |
| 98940 |
|
19 |
13 |
$0.00 |
| 90649 |
|
16 |
13 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
28 |
28 |
$0.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
15 |
14 |
$0.00 |
| 3077F |
|
13 |
13 |
$0.00 |
| 91322 |
|
16 |
16 |
$0.00 |
| 3075F |
|
397 |
383 |
$0.00 |
| 3008F |
|
6,947 |
6,106 |
$0.00 |
| 3074F |
|
1,055 |
1,004 |
$0.00 |
| 3079F |
|
625 |
597 |
$0.00 |
| 3044F |
|
225 |
225 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
27 |
15 |
$0.00 |
| 90680 |
|
13 |
13 |
$0.00 |
| 90480 |
|
14 |
14 |
$0.00 |
| 90716 |
|
19 |
18 |
$0.00 |